Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
Biodesix (NASDAQ:BDSX), a diagnostic solutions company, announced that CFO Robin Cowie will participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth Conference on September 11, 2025, in New York. The CFO will be available for one-on-one meetings with investors during the conference.
Biodesix (NASDAQ:BDSX), azienda di soluzioni diagnostiche, ha comunicato che la CFO Robin Cowie parteciperà al 9th Annual Best Ideas Growth Conference organizzato da Lake Street Capital Markets l'11 settembre 2025 a New York. Durante la conferenza la CFO sarà disponibile per incontri individuali con gli investitori.
Biodesix (NASDAQ:BDSX), una empresa de soluciones diagnósticas, anunció que la directora financiera Robin Cowie participará en la 9th Annual Best Ideas Growth Conference de Lake Street Capital Markets el 11 de septiembre de 2025 en Nueva York. La CFO estará disponible para reuniones individuales con inversores durante la conferencia.
Biodesix (NASDAQ:BDSX)는 진단 솔루션 회사로서 재무책임자(CFO) 로빈 카우이가 2025년 9월 11일 뉴욕에서 열리는 Lake Street Capital Markets의 9th Annual Best Ideas Growth Conference에 참가한다고 발표했습니다. 행사 기간 중 CFO는 투자자들과의 일대일 미팅에 응할 예정입니다.
Biodesix (NASDAQ:BDSX), une société de solutions diagnostiques, a annoncé que la directrice financière Robin Cowie participera à la 9th Annual Best Ideas Growth Conference organisée par Lake Street Capital Markets le 11 septembre 2025 à New York. La CFO sera disponible pour des entretiens individuels avec des investisseurs pendant la conférence.
Biodesix (NASDAQ:BDSX), ein Unternehmen für diagnostische Lösungen, gab bekannt, dass CFO Robin Cowie am 11. September 2025 in New York an der 9th Annual Best Ideas Growth Conference von Lake Street Capital Markets teilnehmen wird. Während der Konferenz steht die CFO für Einzelgespräche mit Investoren zur Verfügung.
- None.
- None.
LOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference on Thursday, September 11, 2025.
Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
Date: Thursday, September 11, 2025
Location: New York, NY
1x1 meetings only
About Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.
Trademarks: Biodesix, Biodesix Logo, Nodify Lung, and IQLung are trademarks or registered trademarks of Biodesix, Inc.
Contacts:
Media:
Natalie St. Denis
Natalie.StDenis@biodesix.com
1-720-925-9285
Investors:
Chris Brinzey
Chris.Brinzey@icrhealthcare.com
1-339-970-2843
